Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zhongzhu Healthcare Holding Co has the GF Score of 54, which implies that the company
might have
Poor future performance potential.
The GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation, which has been found to be closely correlated to the long-term performances of stocks by backtesting from 2006 to 2021. The stocks with a higher GF Score generally generate higher returns than those with lower GF Scores. Therefore, when picking stocks, investors should invest in companies with high GF Scores. The GF Score ranges from 0 to 100, with 100 as the highest rank.
GF Score takes following five key aspects into consideration:
Each one of these components is ranked and the ranks also have positive correlation with the long term performances of stocks. The GF score is calculated using the five key aspects of analysis. Through backtesting, we know that each of these key aspects has a different impact on the stock price performance. Thus, they are weighted differently when calculating the total score. The Profitability Rank and the Growth Rank are weighted fully, while other parameters have less weight.
Based on research and backtesting result, GuruFocus believes Zhongzhu Healthcare Holding Co
might have
Poor future performance potential.
Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.
Zhongzhu Healthcare Holding Co (SHSE:600568) GF Score Explanation
Based on the historical long-term performances among five valuation aspects, the GF Score is found to be closely correlated to the long-term performances of stocks. It ranges from 0 to 100, with 100 as the highest. GuruFocus divided GF Score into following 5 categories:
GF Score
Performance Potential and All-in-One Screener Examples (1)
(1) These are some simple examples. You can access our GF Score filter under All-in-One Screener’s Fundamental tab.
Zhongzhu Healthcare Holding Co GF Score Related Terms
SHSE:600568 vs ZTS, UTHR: GF Score Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's GF Score, along with its competitors' market caps and GF Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongzhu Healthcare Holding Co GF Score vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's GF Score distribution charts can be found below:
* The bar in red indicates where Zhongzhu Healthcare Holding Co's GF Score falls into.
Zhongzhu Healthcare Holding Co (SHSE:600568) has a GF Score of 54 as of Jul. 22, 2026. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Zhongzhu Healthcare Holding Co and its competitors. This is 13% below median its historical median of 62.00. Over the past decade, Zhongzhu Healthcare Holding Co's GF Score has ranged from 28.00 to 78.00.
Is Zhongzhu Healthcare Holding Co's GF Score too high?
Zhongzhu Healthcare Holding Co's current GF Score of 54 is 13% below median its 10-year median of 62.00. Over the past 10 years, this metric has ranged from a low of 28.00 to a high of 78.00. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's GF Score compare to ZTS and UTHR?
Zhongzhu Healthcare Holding Co's GF Score of 54 can be compared against companies in the Drug Manufacturers industry. Historically, Zhongzhu Healthcare Holding Co's own GF Score has ranged from 28.00 to 78.00 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good GF Score for a Drug Manufacturers company?
A good GF Score depends on the Drug Manufacturers industry context. However, GF Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high GF Score mean?
A high GF Score can signal that a stock is expensive relative to its fundamentals. GF Score is a stock performance ranking system developed by GuruFocus using five aspects of valuation. View historical data on Zhongzhu Healthcare Holding Co and its competitors. Zhongzhu Healthcare Holding Co's current GF Score is 54, which is 13% below median its own 10-year median of 62.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.88, compared to a current price of ¥2.20 — trading 17% above its estimated fair value. The current GF Score is 54, which is 13% below median its 10-year median of 62.00. Zhongzhu Healthcare Holding Co's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is GF Score calculated?
GF Score is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current GF Score is 54 as of Jul. 22, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued.
The current stock price of ¥2.20 is trading 17% above its estimated GF Value™ of ¥1.88.
GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.
Key valuation signals for SHSE:600568:
GF Score: 54 (13% below median its 10-year median of 62.00)
GF Value™: ¥1.88 vs. price of ¥2.20 (17% above fair value)
No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongzhu Healthcare Holding Co Business Description
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
54GF Score
Get the complete analysis for SHSE:600568
GF Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600568 has been successfully added to your 
